Lord Alton of Liverpool – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-03-11.

To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 8 March (HL6323), how licence conditions R18-R27 and T97 have been specifically reflected in the patient information and consent forms submitted to the Human Fertilisation and Embryology Authority by the person responsible in order to perform genome editing in human embryos by means of CRISPR-Cas9.

Lord Prior of Brampton

The Human Fertilisation and Embryology Authority (HFEA) has advised that it carried out an audit of the patient information relating to the research project involving genome editing against the requirements of R19 and R20. T97 is not relevant, as it refers to the use of embryos in training, not research. The audit was completed as part of the inspection and feedback provided to the person responsible during the inspection. An assessment was made against the other licence conditions referred to during the inspection. The HFEA does not interpret the requirements to mean that each specific technique that might be used in the research must be specified in the patient information. In this case, the patient information, which is not yet finalised, makes it clear that genes may be altered but does not specifically refer to CRISPR-Cas9.